ANTI-GDF15-ANTIKÖRPER

European patent · EP3689370 · In force

Register entry

Publication number
EP3689370
Application number
EP20156883
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 20, 2013
Published
Aug 5, 2020
Granted
Mar 4, 2026
Protection ends at the latest
Dec 19, 2033
Next annual fee due
Dec 31, 2026
IPC classes
A61K 39/00 (2006.01)
A61K 45/06 (2006.01)
A61P 3/02 (2006.01)
A61P 35/00 (2006.01)
C07K 16/22 (2006.01)
Priority
US 201261745508 P 21.12.2012
US 201361827325 P 24.05.2013
Divided from
EP13827058
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 19, 2026

    Agent entered

    Representative
    VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 19.05.2026

  2. May 7, 2026

    Owner

    Owner
    Aveo Pharmaceuticals, Inc., 30 Winter Street, Boston, MA 02108, USA → Aveo Pharmaceuticals, Inc., One Marina Park Drive, 12th Floor, Boston, MA 02210, USA

    Published in Swissreg on 07.05.2026

  3. Mar 4, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 04.03.2026

Parties

Inventor

LERNER, Lorena

Newton Centre, MA 02459, US

ABBOTT, Sandra

Danvers, MA 01923, US

BAI, Ailin

Newton, MA 02458, US

CHEN, Ting

Acton, MA 01720, US

CHIU, Maria, Isabel

Newton Centre, MA 02459, US

LIU, Qing

Acton, MA 01720, US

POLING, Laura

Acton, MA 01720, US

TAO, Nianjun

Medford, MA 02155, US

WEILER, Solly

Newton, MA 02461, US

WENG, Zhigang

Brookline, MA 02445, US

WINSTON, William, M.

Marlborough, MA 01752, US

GYURIS, Jeno

Lincoln, MA 01773, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.